We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
MicroRNA-Based Therapeutics for Drug-Resistant Colorectal Cancer.
- Authors
Jung, Eunsun; Choi, Jinhyeon; Kim, Jang-Seong; Han, Tae-Su; Iorio, Marilena V.
- Abstract
Although therapeutic approaches for patients with colorectal cancer (CRC) have improved in the past decades, the problem of drug resistance still persists and acts as a major obstacle for effective therapy. Many studies have shown that drug resistance is related to reduced drug uptake, modification of drug targets, and/or transformation of cell cycle checkpoints. A growing body of evidence indicates that several microRNAs (miRNAs) may contribute to the drug resistance to chemotherapy, targeted therapy, and immunotherapy by regulating the drug resistance-related target genes in CRC. These drug resistance-related miRNAs may be used as promising biomarkers for predicting drug response or as potential therapeutic targets for treating patients with CRC. In this review, we summarized the recent discoveries regarding anti-cancer drug-related miRNAs and their molecular mechanisms in CRC. Furthermore, we discussed the challenges associated with the clinical application of miRNAs as biomarkers for the diagnosis of drug-resistant patients and as therapeutic targets for CRC treatment.
- Subjects
THERAPEUTICS; DRUG resistance; CELL transformation; DIAGNOSIS; TARGETED drug delivery
- Publication
Pharmaceuticals (14248247), 2021, Vol 14, Issue 2, p136
- ISSN
1424-8247
- Publication type
Article
- DOI
10.3390/ph14020136